Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

DD1.5k, the Gene Preferentially Expressed in Bloodstream Isolates of Vancomycin-Resistant Enterococcus faecium

  • Kim, Seung-Han (Clinical Research Institute, The Catholic University of Korea) ;
  • Lee, Dong-Gun (Department of Internal Medicine, The Catholic University of Kore) ;
  • Yoo, Jin-Hong (Department of Internal Medicine, The Catholic University of Kore) ;
  • Park, Su-Mi (Department of Internal Medicine, The Catholic University of Kore) ;
  • Park, Jung-Hyun (Department of Internal Medicine, The Catholic University of Kore) ;
  • Shin, Wan-Shik (Department of Internal Medicine, The Catholic University of Kore) ;
  • Lee, Kyungwon (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicin) ;
  • Dongeun Yong (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicin) ;
  • Lee, Wee-Gyo (Department of Laboratory Medicine, Ajou University School of Medicine)
  • Published : 2004.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Vancomycin-resistant Enterococcus faecium (VREFM) is becoming a threatening pathogen. We identified a gene called DD1.5K by differential display-PCR, which was preferentially expressed in the bloodstream isolates of VREFM. Due to its amino acid similarity to transfer complex protein, trsE, and tissue-specific expression, this gene may be involved in virulence of VREFM.

Keywords

References

  1. Arch. Intern. Med. v.158 The role of colonization pressure in the spread of vancomycin-resistant enterococci: an important infection control variable Bonten, M.J.;S. Slaughter;A.W. Ambergen;M.K. Hayden;J. Van Voorhis;C. Nathan;R.A. Weinstein https://doi.org/10.1001/archinte.158.10.1127
  2. 1989-1993. Morb. Mortal, wkly. Rep. v.42 Nosocomial enterococci resisitant to vancomycin- United States Centers for Disease Control and Prevention
  3. N. Engl. J. Med. v.319 Plasmidmediated resistance to vancomycin and teicoplainin in Enterococcus faecium Leclercq, R.;E. Derlot;J. Duval;P. Courvalin https://doi.org/10.1056/NEJM198807213190307
  4. Infect. Control. Hosp. Epidemiol. v.19 Spread of vancomycin-resistant enterococco: why did it happen in the United States? Martone, W.J. https://doi.org/10.1086/647880
  5. Clin. Microbiol. Rev. v.13 Relationships between enterococcal virulence and antimicrobial resistance Mundy, L.M.;D.F. Sahm;M. Gilmore https://doi.org/10.1128/CMR.13.4.513-522.2000
  6. NCCLS document M100-S12 Performance standards for antimicrobial susceptibility testing; 12th informational supplement National Committee for Clinical Laboratory Standards (NCCLS)
  7. J. Infect. Dis. v.187 Rice, L.B.;L.Caris;S. Rudin;C. Vael;H. Goossens;C. Konstabel;I. Klare;S.R. Nallapareddy;W. Huang;B.E. Murray https://doi.org/10.1086/367711
  8. Antimicrob. Agents. Chemother v.33 In vitro susceptibility studies of vancomycin-resistant Entercoccus faecalis Sham, D.F.;J. Kissinger;M.S. Gilmore;P.R. Murray;R. Mulder;J. Soliday;B. Clarke https://doi.org/10.1128/AAC.33.9.1588
  9. J. Infect. Dis. v.172 Epidemiology and mortality risk of vancomycin-resisitant enterococcal bloodstream infections Sahy, D.K.;S.A. Maloney;M. Montecalvo;S. Banerjee;G.P. Wormser;M.J. Arduino;L.A. Bland;W.R. Javis https://doi.org/10.1093/infdis/172.4.993
  10. Lancet 1(8575-8576) Vancomycin resistant enterococci Uttley, A.H.;C.H. Collins;J. Naidoo;R.C. George
  11. Drugs v.58 Antibiotic use in animals: impact on bacterial resistance and public health Van den Bogaard, A.E.;E.E. Strobberingh https://doi.org/10.2165/00003495-199958040-00002
  12. J. Antimicrob. Chemother. v.46 The effect of banning avoparcin on VRE carriage in the Netherlands Van den Bogaard, A.E.;N. Bruinsma;E. E. Stobberingh https://doi.org/10.1093/jac/46.1.146